BERNAMA
OTTAWA, May 2 (Bernama-Xinhua) -- Health Canada on Friday authorised a second generic version of the popular diabetes drug semaglutide, further solidifying the country's position as the first G7 nation to approve alternatives to the brand-name drug Ozempic, reported Xinhua.
Go to News Site